Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
CytomX Therapeutics
90
CytomX Therapeutics
Technology
Biotechnology
CytomX Therapeutics is an early-stage biotechnology company developing Probodies, proteolytically-activated antibodies.
Suggest edits
Founded
2008
Raised
$33.5M
Follow us
Companies in the same industry
Neurovation Labs
IMMUNE Pharmaceuticals Inc.
NeuronTools
Zedi Zedira
ZAGENO Inc.
Univercells
Synthego
Keen Eye Technologies
EdeniQ
Frontier Biotechnologies
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$20,000,000
Venture capital (Series C) - 2015
Canaan Partners
Roche Venture Fund
Third Rock Ventures
+1
$11,000,000
Venture capital (Series B) - 2012
Canaan Partners
Third Rock Ventures
Team Size
10+
Employees
I work here
Location
Guatemala
Headquarters
Explore Guatemala
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when CytomX Therapeutics makes some noise.
